Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

5.6%

1 terminated out of 18 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

22%

4 trials in Phase 3/4

Results Transparency

55%

6 of 11 completed with results

Key Signals

6 with results92% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (5)
P 1 (3)
P 2 (5)
P 3 (3)
P 4 (1)

Trial Status

Completed11
Active Not Recruiting2
Recruiting2
Terminated1
Unknown1
Not Yet Recruiting1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT04744935Not ApplicableActive Not Recruiting

Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma

NCT07384078Not ApplicableNot Yet RecruitingPrimary

High Intensity Focused Ultrasound vs. Cryotherapy in the Treatment of Basal Cell Carcinomas and Bowen's Disease in Adults

NCT03573401Phase 3Active Not RecruitingPrimary

Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).

NCT05381597Phase 2RecruitingPrimary

5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer

NCT04552990Phase 2Completed

Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma

NCT00604890Phase 1CompletedPrimary

Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma

NCT04470726Phase 1CompletedPrimary

Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subtype

NCT00469417Phase 3CompletedPrimary

Metvix Photodynamic Therapy (PDT) Versus Cryotherapy in Participants With Primary Superficial Basal Cell Carcinoma

NCT05713760Phase 2CompletedPrimary

Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults

NCT05628714CompletedPrimary

A Patient Decision Aid for Patients With Superficial Basal Cell Carcinoma

NCT05157763Phase 1RecruitingPrimary

A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma

NCT02270645Not ApplicableCompleted

Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser

NCT03012009Not ApplicableCompleted

Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial

NCT01325688Phase 2CompletedPrimary

PEP005 Gel - Evaluation of the Safety and Efficacy of Ingenol Mebutate Gel on a Superficial Basal Cell Carcinoma on the Trunk or Extremities

NCT00432185Phase 2CompletedPrimary

To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC

NCT00994240Not ApplicableTerminatedPrimary

Cure Rates of Superficial Basal Cell Carcinoma (BCC) EDC

NCT01491711Phase 4UnknownPrimary

Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate

NCT00189306Phase 3CompletedPrimary

Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream

Showing all 18 trials

Research Network

Activity Timeline